Flowable Porcine Urinary Bladder Matrix in Wounds Complicated by Tunneling and Undermining: A Multicenter Prospective Study
Journal of Clinical Medicine · 20.08.2026 · 15 (16) · 6432
DOI: 10.3390/jcm15166432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 20.08.2026. Verfasst von Malachy E Asuku und 12 weiteren Autor:innen. Beteiligte Einrichtung: Integra LifeSciences, Princeton, NJ 08540, USA. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Integra LifeSciences (United States), Integra LifeSciences Corporation, Princeton, NJ, USA.
Abstract (Originalsprache)
Objective
This multicenter, prospective, single-arm study evaluated the safety and preliminary clinical performance of a flowable porcine urinary bladder matrix (UBM) particulate for managing tunneling and undermining features in complex wounds. These features are associated with delayed healing, chronic inflammation, and infection risk. Flowable UBM enables targeted delivery into wound tunnels and cavities.
Method
Twenty-five subjects from 3 United States (U.S.) sites were enrolled, with 21 meeting protocol criteria for analysis (15 with undermining and 6 with tunneling wounds). Participants received flowable UBM applied directly to tunneling or undermining areas, along with additional UBM particulate or sheet forms applied to the wound surface. The primary endpoint was the percentage reduction in tunneling volume or undermining depth at 12 weeks, with secondary assessment of reduction in overall wound volume. Safety was evaluated through evaluation of device-related adverse events.
Results
At 12 weeks, 90.5% of wounds demonstrated positive response, with mean ± standard deviation and median reduction in tunneling or undermining dimensions of 84.6 ± 29.3% and 100.0%, respectively. Complete resolution of these features occurred in 52.4% of wounds (53.3% in undermining and 50.0% in tunneling wounds) with higher closure rates in non-pressure wounds compared to pressure injuries. No device-related adverse events were reported.
Conclusions
Overall, flowable UBM was well tolerated and associated with favorable clinical trajectories demonstrated by reduction in tunneling and undermining dimensions; however, comparative effectiveness cannot be inferred from this limited single-arm pilot study. Further controlled studies are needed to confirm comparative effectiveness and optimize clinical use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Integra LifeSciences, Princeton, NJ 08540, USA.
- Department of Surgery, Section of Trauma and Acute Care Surgery (TACS), University of Colorado Anschutz, Aurora, CO 80045, USA.
- MedStar Health, Washington, DC 20010, USA.
- Northwell Health, Lake Success, NY 11042, USA.
ORCID-Profile: Jessica L Evans, Kristy L Hawley, Alisha Oropallo
Förderung
- Integra LifeSciences (United States)
- Integra LifeSciences Corporation, Princeton, NJ, USA
Zitieren
APA
Asuku, M. E., Baker, H., Mohammedi, S., Xu, W., Jaffee, M., Evans, J. L., Dai, Y., Witherel, C., Duan-Arnold, Y., Hawley, K. L., Cripps, M., Shupp, J. W., & Oropallo, A. (2026). Flowable Porcine Urinary Bladder Matrix in Wounds Complicated by Tunneling and Undermining: A Multicenter Prospective Study. Journal of Clinical Medicine, 15(16), 6432. https://doi.org/10.3390/jcm15166432
Vancouver
Asuku ME, Baker H, Mohammedi S, Xu W, Jaffee M, Evans JL, et al. Flowable Porcine Urinary Bladder Matrix in Wounds Complicated by Tunneling and Undermining: A Multicenter Prospective Study. Journal of Clinical Medicine. 2026;15(16):6432. doi:10.3390/jcm15166432
BibTeX
@article{Asuku2026,
author = {Asuku, Malachy E and Baker, Hannah and Mohammedi, Saarah and Xu, Weiwei and Jaffee, Marcie and Evans, Jessica L and Dai, Yifei and Witherel, Claire and Duan-Arnold, Yi and Hawley, Kristy L and Cripps, Michael and Shupp, Jeffrey W and Oropallo, Alisha},
title = {Flowable Porcine Urinary Bladder Matrix in Wounds Complicated by Tunneling and Undermining: A Multicenter Prospective Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6432},
doi = {10.3390/jcm15166432}
}
EUVIMED